Industry Vet Crystal Muilenburg Joins Elevai’s Board of Directors

Crystal Muilenburg is the newest member of Elevai’s Board of Directors.

A former Evolus and Allergan executive, Muilenburg will play a key role in supporting the Elevai management team as it commercializes Elevai’s flagship exosome product line while driving the market adoption for physician-dispensed topical exosomes.

"I'm thrilled to join Elevai as they lead the aesthetics industry and as they establish a new segment of physician-dispensed skincare products harnessing topical exosomes," says Muilenburg in a news release. "With a science-first approach, an industry-leading management team, and the market's interest in the novel approach to skin leveraging the power of exosomes, Elevai's future is bright."

Most recently, she served as Chief Marketing Officer for Evolus where she led the re-launch of Jeuveau. Prior to Evolus, Muilenburg  was Head of Global Strategic Marketing for Sienna Biopharmaceuticals, a publicly traded, clinical-stage medical dermatology company. Sge also spent more than a decade at Allergan in various leadership roles in US and International marketing and communications where she gained significant FDA approval and commercial launch experience with the company's flagship BOTOX franchise and leading aesthetics brands.

"We are excited to welcome Crystal to ELEVAI's Board," says Elevai Founder Jordan R. Plews, Ph.D. "We believe her track record, accomplishments, and science-first approach will help propel ELEVAI in becoming the preferred topical exosome company as this segment continues to grow in interest and demand."